Cargando…
Modelled mortality benefits of multi-cancer early detection screening in England
BACKGROUND: Screening programmes utilising blood-based multi-cancer early detection (MCED) tests, which can detect a shared cancer signal from any site in the body with a single, low false-positive rate, could reduce cancer burden through early diagnosis. METHODS: A natural history (‘interception’)...
Autores principales: | Sasieni, Peter, Smittenaar, Rebecca, Hubbell, Earl, Broggio, John, Neal, Richard D., Swanton, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307803/ https://www.ncbi.nlm.nih.gov/pubmed/37185463 http://dx.doi.org/10.1038/s41416-023-02243-9 |
Ejemplares similares
-
Cell-Free DNA–Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial
por: Neal, Richard D., et al.
Publicado: (2022) -
Multi-cancer early detection test sensitivity for cancers with and without
current population-level screening options
por: Shao, Spencer H., et al.
Publicado: (2022) -
Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control Study
por: Castanon, Alejandra, et al.
Publicado: (2022) -
By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016) -
A case-control study to evaluate the impact of the breast screening programme on mortality in England
por: Maroni, Roberta, et al.
Publicado: (2020)